Variant report
Variant | esv2759668 |
---|---|
Chromosome Location | chr9:10639445-10680025 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs143898388 | chr9:10640447-10640448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs530527249 | chr9:10640482-10640483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs984119 | chr9:10640526-10640527 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs554366643 | chr9:10640531-10640532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs566943483 | chr9:10640549-10640550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146864409 | chr9:10640558-10640559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189799143 | chr9:10640591-10640592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs112967905 | chr9:10640595-10640596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs555479015 | chr9:10640600-10640601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs538871169 | chr9:10640647-10640648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs377286188 | chr9:10640718-10640719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558475457 | chr9:10640720-10640721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs140722574 | chr9:10640771-10640772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs538358763 | chr9:10640773-10640774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182468141 | chr9:10640783-10640784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs574916289 | chr9:10640786-10640787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs16926225 | chr9:10648878-10648879 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs541172758 | chr9:10648890-10648891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs1923439 | chr9:10648898-10648899 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs533244629 | chr9:10648901-10648902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs142009666 | chr9:10648927-10648928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs563321729 | chr9:10648941-10648942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs571188269 | chr9:10648968-10648969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs376801422 | chr9:10648993-10648994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs529581736 | chr9:10649043-10649044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs536984164 | chr9:10649064-10649065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs556729189 | chr9:10649068-10649069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs549617923 | chr9:10649089-10649090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs538892842 | chr9:10649093-10649094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs566149831 | chr9:10649105-10649106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs528637466 | chr9:10649152-10649153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs551999063 | chr9:10649180-10649181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs557413679 | chr9:10649191-10649192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs570599231 | chr9:10649199-10649200 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs539522764 | chr9:10649299-10649300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs1322303 | chr9:10649309-10649310 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs569602375 | chr9:10649369-10649370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs535396515 | chr9:10649376-10649377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs1998341 | chr9:10649385-10649386 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs572248457 | chr9:10649496-10649497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs114364399 | chr9:10649595-10649596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs557514659 | chr9:10649616-10649617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs2208707 | chr9:10649660-10649661 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
44 | rs78188559 | chr9:10649751-10649752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs563356738 | chr9:10649807-10649808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs529247146 | chr9:10649814-10649815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs542955120 | chr9:10649870-10649871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs62537582 | chr9:10649873-10649874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs74906141 | chr9:10649911-10649912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs552035913 | chr9:10649968-10649969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Renal cell carcinoma | 21215367 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:10640400-10640800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr9:10648800-10650000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
3 | chr9:10661200-10662200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr9:10661400-10662400 | Enhancers | Fetal Heart | heart |
5 | chr9:10673800-10675200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr9:10674400-10675200 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
7 | chr9:10674400-10675200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr9:10674800-10675200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr9:10675800-10676000 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr9:10675800-10676000 | Bivalent/Poised TSS | Breast Myoepithelial Primary Cells | Breast |
11 | chr9:10676000-10677600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr9:10678400-10679000 | Enhancers | NH-A | brain |